regulatory submissions

Pharmaceutical companies are reporting that artificial intelligence is already cutting measurable time from clinical trials and the heavy paperwork that surrounds regulatory submissions — not by inventing new drugs overnight, but by streamlining the “messy middle” of development: site selection...